Turmeric, a common spice, has been used in Eastern medicine for centuries. Studies are now examining the benefits of yellow ...

Teens with seborrheic dermatitis are most ... If you have sensitive scalp skin, it may help to shampoo less frequently. Scalp psoriasis. This autoimmune condition causes skin cells to reproduce ...

I tried the SickScience ShapeShift Jaw Defining Serum and it tightened, firmed, and hydrated my neck and jawline in six weeks ...

Dermatology-trained pharmacists at Boots can now provide free, in-store support on skin conditions like acne, rosacea, and ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...

A total of 432 patients (56.3% women) aged 12 and older with psoriasis on the scalp and body were randomly assigned to two groups, one of which used roflumilast foam 0.3% once a day for eight ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and ...

Roflumilast foam 0.3% applied once daily led to significantly greater clearance of scalp and body plaque psoriasis lesions and more rapid itch reduction than placebo over eight weeks.

Once-daily 0.3% topical roflumilast foam significantly reduced severity in patients with psoriasis of the scalp and body over 8 weeks, with a favorable safety profile. “Use of roflumilast foam ...